We have been searching for inhibitors for Epstein-Barr virus early antigen (EBV-EA) activation in plants and callus cells. We have induced callus cell lines from various plants and found that triterpenes contained in Sesamum indicum L. callus cells showed anti-tumor promoter activity. In this paper we describe isolation, characterization and anti-tumor promoter activity of triterpens in S. indicum L. callus.
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We have been searching for inhibitors for Epstein-Barr virus early antigen (EBV-EA) activation in plants and callus cells. We have induced callus cell lines from various plants and found that triterpenes contained in Sesamum indicum L. callus cells showed anti-tumor promoter activity. In this paper we describe isolation, characterization and anti-tumor promoter activity of triterpens in S. indicum L. callus.
For the induction of the callus, we used segments of the seedling of S. indicum L. 1). The callus cells were cultured in modified Murige-Skoog1)2) liquid medium at 35C with aeration. The cells (23.3kg-Fresh Weight) were extrad with EtOH-H2O (4 :1) (721x3) and the extct was dried in vacuo. The dried exact was applied on an Ambite XAD-2 (Organo) column (160 x 1300 mm) and successively eluted with H2O, McOH-H2O ( Mega Bond Elut C18 (Varian Associates, Inc. ) eluted with McOH-H2O (7:3). The McOH-H2O (7:
3) fraction was dried in vacuo. The dried fraction was applied to Develosil Lop ODS (Nomura The 13C-NMR spectrum showed double bonded carbon signals assignable to C-12 and C-13 at 125. 4 and 139. 2, respectively, and the carbon signal due to C-28 at 179. 7. The 13C-NMR spectrum of compound 1 was similar to that of 2a, 3a, 23-trihydroxyurs-l2-en-28-oic-acid (esculentic acid)3) ( Table 1 ).
The compound 1 was identified as esculentic acid by comparison with published spectral data3).
Esculentic acid has been isolated from Diplazium esculentum4) and the fruit galls of Actinidia polygama3), yet their biological activities have not been fully investigated. Compound 2 was identified as 38-(trans-p-coumaroyloxy) -2a, 23-dihydroxyurs-l2-en-28-oic acid by comparison with published spectral data3) ( Table 2 ). This compound has been isolated from the fruit galls of Actinidia polygama3).
The inhibition of EBV-EA activation5) was assayed using the Epstein-Barr virus (EBV) genome -carrying human lymphoblastoid cells, Raj i (non-virus producer), which were cultivated in RPMI 1640 medium supplemented with 10% fetal bovine serum. The indicator cells (Raji) (1 x 106/ml) were incubated at 3TC for 48h in 1.0 ml of the medium containing 4 mM of n-butyric acid, 8.1 pM of TPA and a test compound.
The activated cells were stained by high titer EBV-positive sera from nasophayngeal carcinoma patients and detected by a conventional indirect immunofluorescence technique.
In each assay, at least 200 cells were counted, and the experiments were repeated twice.
Esculentic acid (compound 1) and 3b-(traps-p-coumaroyloxy) -2a, 23-dihydroxyurs-l2-en-28-oic acid (compound 2) were purified from the callus cells and they were tested using the short-term in vitro assay of EBV-EA activation in Raji cells induced by 12-0-tetradecanoylphorbol-l3-acetate (TPA) 6). Their inhibitory effects on activation are shown in Table 3 . Inhibitory effects on EBV activation of compound 1 and 2 were nearly equal to those of retinoic acid. Viabilities of exponentially growing Raji cells were about 85%. Neither compound 1 nor 2 show any cytotoxicity at 4 pg/ml. Previously it was reported that arjunolic acid, an oleanene triterpene(2a, 3b, 23 -trihydroxy-olean-l2-en-28-oic acid), suppressed skin tumor promotion in mice7). Its structure is similar to compound 1. Compound 1 has two methyl groups at C-19 and C-20 positions of E ring but arjunolic acid has two methyl groups at C-20 position of E ring. Except for this point, compound 1 and arjunolic acid have almost the same structure.
